Literature DB >> 17376894

Host transcription profiles upon primary respiratory syncytial virus infection.

Riny Janssen1, Jeroen Pennings, Hennie Hodemaekers, Annemarie Buisman, Marijke van Oosten, Lia de Rond, Kemal Oztürk, Jan Dormans, Tjeerd Kimman, Barbara Hoebee.   

Abstract

Respiratory syncytial virus (RSV) is a common cause of severe lower respiratory tract infection in children. Severe RSV disease is related to an inappropriate immune response to RSV resulting in enhanced lung pathology which is influenced by host genetic factors. To gain insight into the early pathways of the pathogenesis of and immune response to RSV infection, we determined the transcription profiles of lungs and lymph nodes on days 1 and 3 after infection of mice. Primary RSV infection resulted in a rapid but transient innate, proinflammatory response, as exemplified by the induction of a large number of type I interferon-regulated genes and chemokine genes, genes involved in inflammation, and genes involved in antigen processing. Interestingly, this response is much stronger on day 1 than on day 3 after infection, indicating that the strong transcriptional response in the lung precedes the peak of viral replication. Surprisingly, the set of down-regulated genes was small and none of these genes displayed strong down-regulation. Responses in the lung-draining lymph nodes were much less prominent than lung responses and are suggestive of NK cell activation. Our data indicate that at time points prior to the peak of viral replication and influx of inflammatory cells, the local lung response, measured at the transcriptional level, has already dampened down. The processes and pathways induced shortly after RSV infection can now be used for the selection of candidate genes for human genetic studies of children with severe RSV infection.

Entities:  

Mesh:

Year:  2007        PMID: 17376894      PMCID: PMC1900269          DOI: 10.1128/JVI.02220-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays.

Authors:  Tony Yuen; Elisa Wurmbach; Robert L Pfeffer; Barbara J Ebersole; Stuart C Sealfon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

3.  A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children.

Authors:  Eun Hwa Choi; Hoan Jong Lee; Taiwoo Yoo; Stephen J Chanock
Journal:  J Infect Dis       Date:  2002-10-11       Impact factor: 5.226

4.  Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.

Authors:  Eric A Simoes; Xavier Carbonell-Estrany
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

5.  Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection.

Authors:  Rik L De Swart; Thijs Kuiken; Helga H Timmerman; Geert van Amerongen; Bernadette G Van Den Hoogen; Helma W Vos; Herman J Neijens; Arno C Andeweg; Albert D M E Osterhaus
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.

Authors:  H A Haeberle; W A Kuziel; H J Dieterich; A Casola; Z Gatalica; R P Garofalo
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 7.  The pathogenesis of respiratory syncytial virus disease in childhood.

Authors:  Paul S McNamara; Rosalind L Smyth
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

8.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Authors:  E A Kurt-Jones; L Popova; L Kwinn; L M Haynes; L P Jones; R A Tripp; E E Walsh; M W Freeman; D T Golenbock; L J Anderson; R W Finberg
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

9.  Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice.

Authors:  Anita Boelen; Joan Kwakkel; Marion Barends; Lia de Rond; Jan Dormans; Tjeerd Kimman
Journal:  J Med Virol       Date:  2002-04       Impact factor: 2.327

10.  Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms.

Authors:  Barbara Hoebee; Edwin Rietveld; Louis Bont; Marijke van Oosten; Hennie M Hodemaekers; Nico J D Nagelkerke; Herman J Neijens; Jan L L Kimpen; Tjeerd G Kimman
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

View more
  28 in total

1.  Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.

Authors:  Annemieke Schuurhof; Louis Bont; Jeroen L A Pennings; Hennie M Hodemaekers; Piet W Wester; Annemarie Buisman; Lia C G H de Rond; Myra N Widjojoatmodjo; Willem Luytjes; Jan L L Kimpen; Riny Janssen
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

2.  Replication of respiratory syncytial virus is inhibited by the host defense molecule viperin.

Authors:  Glen McGillivary; Zachary B Jordan; Mark E Peeples; Lauren O Bakaletz
Journal:  J Innate Immun       Date:  2012-09-25       Impact factor: 7.349

3.  Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs.

Authors:  Fatoumata B Sow; Jack M Gallup; Alicia Olivier; Subramaniam Krishnan; Andriani C Patera; JoAnn Suzich; Mark R Ackermann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-08       Impact factor: 5.464

Review 4.  The ISG56/IFIT1 gene family.

Authors:  Volker Fensterl; Ganes C Sen
Journal:  J Interferon Cytokine Res       Date:  2010-10-15       Impact factor: 2.607

5.  Respiratory syncytial virus inhibits lung epithelial Na+ channels by up-regulating inducible nitric-oxide synthase.

Authors:  Weifeng Song; Gang Liu; Charles A Bosworth; John R Walker; George A Megaw; Ahmed Lazrak; Edward Abraham; Wayne M Sullender; Sadis Matalon
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

6.  A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection.

Authors:  Keyur A Dave; Emma L Norris; Alexander A Bukreyev; Madeleine J Headlam; Ursula J Buchholz; Toshna Singh; Peter L Collins; Jeffrey J Gorman
Journal:  Mol Cell Proteomics       Date:  2014-08-08       Impact factor: 5.911

7.  Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

Authors:  Matthew R Murawski; Glennice N Bowen; Anna M Cerny; Larry J Anderson; Lia M Haynes; Ralph A Tripp; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

8.  Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae.

Authors:  Glen McGillivary; Kevin M Mason; Joseph A Jurcisek; Mark E Peeples; Lauren O Bakaletz
Journal:  Cell Microbiol       Date:  2009-06-02       Impact factor: 3.715

9.  Suppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species.

Authors:  Ke Ren; Yuanzi Lv; Yujie Zhuo; Changmai Chen; Hengfei Shi; Lin Guo; Guang Yang; Yayi Hou; Ren Xiang Tan; Erguang Li
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

10.  Comparison of clastogen-induced gene expression profiles in wild-type and DNA repair-deficient Rad54/Rad54B cells.

Authors:  Anuska G Mahabir; Mirjam M Schaap; Jeroen L A Pennings; Jan van Benthem; Coenraad F M Hendriksen; Harry van Steeg
Journal:  BMC Genomics       Date:  2010-01-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.